Ghe xe diverse opsion de tratamento pa'l cancro de prostata, a seconda del stadio e de l'agressività del cancro, come anca dea salute generale e dee preferense personałi del pasiente.
Alcuni tratamenti comuni i include:
1. Sorvełansa ativa: Sto metodo el implica un atento monitoragio del cancro co controłi e test regołari, pitosto che scominsiar el tratamento imediatamente.
Podaria esar adato pa i òmeni co un cancro ała prostata a basso riscio.
2. Chirurgia: 'na prostatectomia xe 'na procedura chirurgica pa cavar a prostata.
Se pol farla co chirurgia verta o laparoscopica (usando piccole incision e strumenti speciałi).
3. Radioterapia:'sto tratamento usa radiazioni de alta energia pa copar e cellule cancerose.
El pol esar somministrà esternamente (da na machina fora del corpo) o internamente (traverso inpianti posti visin al tumore).
4. Terapia ormonale:'sto tratamento el riduce i livełi dei ormoni maschiłi (androgeni) nel corpo, che pol ralentar o fermar a cressita del cancro de prostata.
El pol esar usà da soło o in conbinasion co altri tratamenti.
5. Chimioterapia:'sto tratamento usa droghe pa copar e cellule del cancro.
El pol essar usà pa'l cancro ała prostata in stadio avanzà che se ga sparso in altre parti del corpo.
6. Immunoterapia:'sto tratamento aiuta el sistema immunitario a combatar el cancro.
El pol essar usà pa'l cancro de prostata in stadio avansà che no ga risposto a altri tratamenti.
7. Terapia mirà:'sto tratamento mira a geni o proteine specifici che iuta e cellule cancerose a cressar e sopravvivar.
El pol essar usà pa'l cancro de prostata in stadio avansà che no ga risposto a altri tratamenti.
8. Crioterapia:'sto tratamento usa un freddo estremo pa congełar e copar e cellule cancerose.
El pol essar usà pa'l cancro de prostata in fase iniziale o pa'l cancro che xe ritornà dopo altri tratamenti.
9. Ultrasuoni focałixai ad alta intensità (HIFU): Sto tratamento usa onde sonore ad alta frequensa pa scaldar e distrugger e cellule cancerose.
El pol essar usà pa'l cancro de prostata in fase iniziale o pa'l cancro che xe ritornà dopo altri tratamenti.
10. Aspettativa vigile: Sto metodo implica el monitoragio atento del cancro co controłi e test regolari, ma no el scumisio del tratamento se no i sintomi no i se presenta o canbia.
Pol esar adato pa i omeni veci col cancro ała prostata a lenta cressita e altre gravi condision de salute.
Xe importante discutar tute e opsion de tratamento co un grupo de cura par determinàr el mejo modo de far par ogni caso individuale.
Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.
Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.
Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.
Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.
Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.
['Disclaimer: medego']
['Sto sito web el xe fornìo solo par scopi educativi e informativi e no el costituise un consejo mèdego o servisi profesionali.']
['Łe informasion fornìe no łe ga da esar usà pa diagnosticar o curar un problema de salute o na malatia, e chi che serca un consijo mèdego personal el ga da consultar un mèdego licensià.']
['Te prego de notare che a rete neurałe che ła genera risposte ałe domande, ła xe particołarmente imprecisa quando se trata de contenuti numèrici, par exenpio el nùmaro de persone a cui xe stà diagnosticà na determinada małatia.']
['Serca senpre el consijo del to dotor o de un altro fornitor de sałute cualificà riguardo a na condision mèdega. Mai trascurar el consijo mèdego profesionałe o ritardarlo nel sercarlo par via de calcossa che te ghè leto su sto sito. Se te pensi de aver na emergensa mèdega, ciama el 911 o va al pronto socorso pì visin imediatamente.']
['Disclaimer: copyright']
['El Digital Millennium Copyright Act del 1998, 17 U.S.C. § 512 (el DMCA) el dà ricorso ai proprietari de copyright che i crede che el material che vien fora su Internet infranga i so diriti soto ła lege sui copyright dei Stati Uniti. ']
["Se te credi in bona fede che un contenuto o un material messo a dispoxision in conesion col nostro sito o i nostri servisi infranga i to diriti de autor, ti (o el to agente) te pol mandarne na notisia domandando che el contenuto o el material sia rimoso, o che l'acesso sia blocà."]
['I avixi i ga da esare mandà par scrito via e-mail (varda ła sezion "Contato" pa\'l indiriso e-mail).']
["El DMCA richiede che a to notisia de presunta violasion de copyright includa e seguenti informasion: (1) descrixion del lavoro proteto da copyright che xe l'ogeto de ła presunta violasion; (2) descrixion del presunto contenuto che viola e informasion sufisente par permeterne a noi de localixar el contenuto; (3) informasion de contato, incluxo el to indirizo, numero de telefono e indirizo email; (4) na dichiarasion da parte tua che te credi in bona fede che el contenuto nel modo reclamà no xe autorizà dal proprietario del copyright, o dal so agente, o da l'operasion de nisuna lege; "]
["(5) 'na to dichiarasion, firmada soto pena de spergiuro, che łe informasion neła notìfega xe precise e che te ghè l'autorità de far valer i diriti de autor che i xe stai violadi;"]
['e (6) na firma fisica o ełetrònica del titołare del copyright o de na persona autorizada a agire a nome del titołare del copyright. ']
['Se no te meti tute łe informasion sora łe pol far in modo che el tratamento del to reclamo el se intardi.']
['Contato']
['Ve prego de mandarne na mail co qualsiasi domanda/suggerimento.']
How to treat prostate cancer?
There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.
Some common treatments include:
1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.
It may be suitable for men with low-risk prostate cancer.
2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.
It can be done through open surgery or laparoscopically (using small incisions and specialized tools).
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).
4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.
It can be used alone or in combination with other treatments.
5. Chemotherapy: This treatment uses drugs to kill cancer cells.
It may be used for advanced prostate cancer that has spread to other parts of the body.
6. Immunotherapy: This treatment helps the immune system fight cancer.
It may be used for advanced prostate cancer that has not responded to other treatments.
7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.
It may be used for advanced prostate cancer that has not responded to other treatments.
8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.
It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.
It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Circa']
['BioMedLib usa computer automatici (algoritmi de machine-learning) pa generar coppie de domande e risposte.']
['Cominsiemo co 35 milioni de publicassioni biomediche de PubMed/Medline. e anca pagine web de RefinedWeb.']
